Fresenius Medical Care AG & Co. KGaA ADR (FMS)
NYSE
Closed
Aug 24, 2026
Day's Range
23.3952 wk Range
20.02Overview - FMS - Fresenius Medical Care AG & Co. KGaA ADR
Key Statistics
Valuation
Enterprise Value
27.27B
P/E (Trailing)
‪12.07‬
P/E (Forward)
‪6.37‬
PEG Ratio
‪2.32‬
Price / Sales (TTM)
‪0.64‬
Price / Book
‪0.85‬
EV / EBITDA
‪8.58‬
Profitability
Gross Margin
‪26.95%‬
Profit Margin
‪4.82%‬
Operating Margin
‪10.77%‬
Return on Assets
‪3.98%‬
Return on Equity
‪8.52%‬
Ownership
Shares Outstanding
266.10M
Float
363.78M
Held by Insiders
‪0.00%‬
Held by Institutions
‪9.91%‬
Price stats
Beta
‪0.83‬
50-Day Avg
‪23.92‬
200-Day Avg
‪23.16‬
Dividends
Payout Ratio
‪45.02%‬
Frequency
Annual
Analyst Consensus
7 analysts
Average price target
‪$ 25.84‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - FMS - Fresenius Medical Care AG & Co. KGaA ADR
Peers - FMS - Fresenius Medical Care AG & Co. KGaA ADR
Peer Comparison
Compared with companies in Medical Care Facilities listed on NYSE.
Profile Summary - FMS - Fresenius Medical Care AG & Co. KGaA ADR
About
Fresenius Medical Care AG & Co. KGaA ADR represents shares of the global healthcare company specializing in dialysis treatments and related products. The primary function of Fresenius Medical Care is to provide comprehensive care for patients suffering from chronic kidney failure. This includes offering dialysis…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
